SCHEMBL1032453

SCHEMBL1032453

O=C(Nc1cccc(-c2ccnc(NC3CCCCC3)n2)c1)C1CC1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABL1 P00519 1/20 0.66
PDGFRB P09619 1/20 0.66
BCR P11274 1/20 0.66
SRC P12931 1/20 0.66
PDGFRA P16234 1/20 0.66
JAK2 O60674 2/20 0.54
DGAT1 O75907 1/20 0.52
HPGD P15428 2/20 0.49
SMN1; SMN2 Q16637 2/20 0.49
ALDH1A1 P00352 2/20 0.49
CNR1 P21554 1/20 0.49
KDM4E B2RXH2 1/20 0.49
USP2 O75604 1/20 0.49
POLB P06746 1/20 0.49
TSHR P16473 1/20 0.49
HSD17B10 Q99714 1/20 0.49
L3MBTL1 Q9Y468 1/20 0.49
ADORA1 P30542 3/20 0.49
PLK1 P53350 1/20 0.47
ADORA3 P0DMS8 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1030447 0.80 MAPK14 (0.52) JAK2DGAT1GSK3BMAPK8PIK3CG
SCHEMBL29131118 0.80 JAK2 (0.61) ABL1PDGFRBBCRSRCPDGFRA
SCHEMBL30668832 0.80 JAK2 (0.61) ABL1PDGFRBBCRSRCPDGFRA
SCHEMBL1033626 0.79 CDK1 (0.53) JAK2DGAT1KDM4EGSK3BMAPK8
SCHEMBL1365 0.79 ABL1 (1.00) ABL1PDGFRBBCRSRCPDGFRA
SCHEMBL1033986 0.79 PTK2 (0.49) ABL1PDGFRBBCRSRCPDGFRA
SCHEMBL1034632 0.78 HDAC8 (0.51) ABL1PDGFRBBCRSRCPDGFRA
SCHEMBL1034808 0.78 AURKA (0.55) DGAT1HPGDSMN1; SMN2KDM4EHSD17B10
SCHEMBL1034911 0.77 ROCK2 (0.57) JAK2DGAT1GSK3BMAPK1AURKA
SCHEMBL3619159 0.77 ADORA1 (0.59) JAK2DGAT1ADORA1PLK1GSK3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011008931-A2 ARYLPYRIMIDINE COMPOUNDS AND COMBINATION THERAPY COMPRISING SAME FOR TREATING CYSTIC FIBROSIS & RELATED DISORDERS CYSTIC FIBROSIS FOUNDATION THERAPEUTICS, INC. (US) 2011-01-20 WO disclosed
WO-2010151747-A1 PYRIMINE COMPOUNDS AND METHODS OF MAKING AND USING SAME CYSTIC FIBROSIS FOUNDATION THERAPEUTICS, INC. (US) 2010-12-29 WO disclosed